[18F]F-FAPI与[18F]F-FDG PET/CT诊断阴茎鳞癌可疑淋巴结转移的前瞻性初步研究
该前瞻性初步研究纳入25例病理确诊的阴茎鳞状细胞癌(PSCC)患者,在根治性腹股沟淋巴结清扫前30天内行[18F]F-FAPI和[18F]F-FDG PET/CT,以术后病理为参考标准。患者水平分析显示[18F]F-FAPI PET/CT的N分期准确率为100%,[18F]F-FDG为72%。病灶水平分析显示[18F]F-FAPI的灵敏度、特异度、PPV和准确率分别为0.96、1.00、1.00和99.8%,均优于[18F]F-FDG。
要点
- [18F]F-FAPI PET/CT在PSCC患者水平N分期准确率达100%,高于[18F]F-FDG的72%。
- 病灶水平[18F]F-FAPI的灵敏度0.96、特异度1.00、PPV 1.00、准确率99.8%。
- 转移淋巴结FAP和GLUT1表达均升高,FAPI摄取与FAP表达正相关。
核心结论
- [18F]F-FAPI PET/CT在检测PSCC患者腹股沟淋巴结转移方面显示出优于[18F]F-FDG的诊断性能,可能有助于优化腹股沟淋巴结清扫的患者选择并减少不必要的手术并发症。
研究设计与样本
- 前瞻性初步研究,纳入25例病理确诊的PSCC患者,均接受[18F]F-FAPI和[18F]F-FDG PET/CT,并在30天内行根治性腹股沟淋巴结清扫,以术后病理为参考标准。
主要发现
- 25例可评估患者中12例(48%)病理确诊淋巴结转移;患者水平分析[18F]F-FAPI PET/CT的N分期准确率为100%,[18F]F-FDG为72%。
- 病灶水平分析共清扫447枚淋巴结,其中27枚证实为转移;[18F]F-FDG vs [18F]F-FAPI的灵敏度为0.89(95% CI: 0.71-0.97)vs 0.96(95% CI: 0.81-1.00)。
- 特异性为0.93(95% CI: 0.90-0.95)vs 1.00(95% CI: 0.99-1.00);PPV为0.44(95% CI: 0.35-0.53)vs 1.00(95% CI: 0.87-1.00);准确率为92.2% vs 99.8%。
- 转移淋巴结的SUVmax、SUVmean和TBR显著高于良性淋巴结,[18F]F-FAPI显示出更优的鉴别能力。
- 免疫组化显示转移淋巴结中FAP和GLUT1表达均显著升高,FAP上调更明显;FAPI摄取与FAP表达正相关,FDG摄取与GLUT1表达正相关。
临床怎么用
- 对于局部晚期PSCC患者,[18F]F-FAPI PET/CT可能提高腹股沟淋巴结转移的诊断准确性,辅助筛选需行淋巴结清扫的患者。
局限性
- 本研究为前瞻性初步研究,样本量较小(25例患者,27枚转移淋巴结)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the potential value of [18F]F-FAPI PET/CT for detecting inguinal lymph node (ILN) metastases in locally advanced penile squamous cell carcinoma (PSCC) and to compare the results with those of [18F]F-FDG PET/CT. METHODS: In this prospective pilot study, 25 patients with histologically confirmed PSCC underwent both [18F]F-FAPI and [18F]F-FDG PET/CT followed by radical ILN dissection within 30 days. Diagnostic performance was assessed using postoperative histopathology as the reference. Semi-quantitative parameters (SUVmax, SUVmean, tumor-to-background ratio (TBR)) were analyzed, and immunohistochemical staining for FAP and GLUT1 was performed on resected lymph nodes to assess correlations with PET-derived metrics. RESULTS: Among 25 evaluable patients, 12 (48%) had pathologically confirmed lymph node metastases. On a patient-based analysis showed [18F]F-FAPI PET/CT achieved 100% accuracy in N-staging, compared to 72% for [18F]F-FDG PET/CT. On a lesion-based analysis, a total of 447 lymph nodes were dissected, of which 27 were confirmed as metastases. The sensitivity, specificity, positive predictive value, and accuracy for [18F]F-FDG vs. [18F]F-FAPI PET/CT were as follows: sensitivity, 0.89 (95% CI: 0.71-0.97) vs. 0.96 (95% CI: 0.81-1.00); specificity, 0.93 (95% CI: 0.90-0.95) vs. 1.00 (95% CI: 0.99-1.00); PPV, 0.44 (95% CI: 0.35-0.53) vs. 1.00 (95%CI: 0.87-1.00); and accuracy, 92.2% vs. 99.8%, respectively. Metastatic lymph nodes exhibited significantly higher SUVmax, SUVmean, and TBR than benign nodes, with [18F]F-FAPI demonstrating superior discriminative ability. Immunohistochemical analysis revealed markedly elevated expression of both FAP and GLUT1 in metastatic nodes than in benign nodes, with FAP upregulation being more pronounced. FAPI uptake correlated positively with FAP expression, whereas FDG uptake correlated positively with GLUT1 expression. CONCLUSION: [18F]F-FAPI PET/CT demonstrates promising diagnostic performance in detecting ILN metastases in patients with PSCC compared to [18F]F-FDG. This modality holds potential value in refining patient selection for inguinal lymph node dissection and reducing unnecessary surgical morbidity. TRIAL REGISTRATION: ChiCTR2400085605. https://www.chictr.org.cn .
引用
- Ouyang W, Tong X, Hou W, et al. Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42213124. doi:10.1007/s00259-026-07961-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。